Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome

Ronald McGregor1,2, Ming-Fung Wu3,2, Brent Holmes2,4

  • 1Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90095 icelos3@gmail.com.

Insights

Chronic morphine exposure increases hypocretin/orexin (Hcrt) innervation in the locus coeruleus, impacting opioid withdrawal. This Hcrt system manipulation may offer new avenues for treating opioid addiction.

Area of Science:

  • Neuroscience
  • Addiction Research
  • Neuropharmacology

Background:

  • Previous studies indicated increased hypocretin/orexin (Hcrt)-producing neurons in human heroin addicts and morphine-exposed mice.
  • The role of Hcrt system changes in opioid withdrawal targets, like the locus coeruleus (LC), remained unclear.

Purpose of the Study:

  • To investigate the impact of increased Hcrt neuron number on Hcrt innervation in opioid withdrawal-related brain regions.
  • To determine the relationship between Hcrt innervation and tyrosine hydroxylase (TH) levels in the LC during morphine withdrawal.

Main Methods:

  • Immunohistochemistry
  • Biochemical assays
  • Imaging techniques
  • Behavioral analysis

Main Results:

  • Morphine administration significantly increased Hcrt innervation and tyrosine hydroxylase (TH) levels in the locus coeruleus (LC) without altering norepinephrine neuron numbers.
  • The observed increase in TH levels in the LC was dependent on Hcrt innervation.
  • The A1/A2 medullary regions were not affected by morphine treatment.
  • Eliminating Hcrt neurons prevented the TH increase in the LC and reduced opioid withdrawal symptoms.

Conclusions:

  • Hypothalamic Hcrt innervation of the LC is significantly upregulated by chronic morphine exposure.
  • This Hcrt system modulation plays a crucial role in the neurobiological adaptations underlying opioid addiction and withdrawal.
  • Targeting the Hcrt system presents a potential therapeutic strategy for opioid addiction and withdrawal management.

Related Concept Videos

Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.8K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
917
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
229
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
792
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
500